Sign inJoin waitlistJoin the waitlist

SH

Stuart Holden

Co-Director, UCLA Institute of Urologic Oncology · UCLA David Geffen School of Medicine/UCLA Medical Center

Credentials: · · ·

History

UCLA Institute of Urologic Oncology Center · UCLA David Geffen School of Medicine/UCLA Medical Center
Present

Urology
1969–1974
Cornell Univ Joan and Sanford I Weill Med Coll
1964–1968

Research

Ligand for peroxisome proliferator-activated receptor gamma (troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo
Cancer Research · 1998 · 562 citations
Diagnostic Accuracy of 68Ga-PSMA-11 PET for Pelvic Nodal Metastasis Detection Prior to Radical Prostatectomy and Pelvic Lymph Node Dissection: A Multicenter Prospective Phase 3…
JAMA Oncology · 2021 · 311 citations
Inhibition of proliferation of prostate cancer cells by a 19-nor-hexafluoride vitamin D3 analogue involves the induction of p21waf1, p27kip1 and E-cadherin
Journal of Molecular Endocrinology · 1997 · 153 citations

Harold Koeffler
6 papers
Allan Pantuck
4 papers
Andrew Lenis
4 papers · 4 as a resident
Arie Belldegrun
4 papers
Karim Chamie
4 papers
Nicholas Donin
4 papers · 4 as a fellow
AZ
Anthony Zietman
3 papers
Beatrice Knudsen
3 papers
Daniel Lin
3 papers
HS
Howard Sandler
3 papers
Jesse McKenney
3 papers
John Gore
3 papers